Enliven Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burlingame, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Enliven Therapeutics, Inc. has filed 784 SEC EDGAR filings since 21 Apr 2016

SEC filing history

Showing 601-625 of 784 matching filings.

Per page
25
Current page
25
4

OWNERSHIP DOCUMENT

Filing date
19 Oct 2022
Reporting date
17 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
19 Oct 2022
Reporting date
17 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39247

DEFA14A

Filing date
19 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-39247

425

Filing date
14 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-39247

425

Filing date
13 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFM14A File 001-39247

DEFM14A

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14A File 001-39247

PREM14A

Filing date
23 Sep 2022
Reporting date
23 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39247

DEFA14A

Filing date
07 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2022
Reporting date
16 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jun 2022
Reporting date
03 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91465

NEW ENTERPRISE ASSOCIATES 14, L.P. -- IMARA INC. 13DA3E

Filing date
24 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 May 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .